First Look at LIBRETTO-432 Results: Dr. Monty Pal on ASCO26 Plenary Research
561 ditonton
31 May 2026
⏱ 2:03
Dr. Monty Pal of City of Hope analyzes the results of the LIBRETTO-432 trial assessing event-free survival with adjuvant selpercatinib in stage IB-IIIA RET fusion-positive non-small cell lung cancer. Read the full abstract (LBA3) from the 2026 ASCO Annual Meeting: https://www.asco.org/abstracts-presentations/260410 For more on ASCO26, visit https://dailynews.ascopubs.org/meetings/asco-annual-meeting _Data as of May 7, 2026_
Video Lainnya
0:44
A New Breakthrough in Pancreatic Cancer Offers Hope
254 ditonton
1:12
Questions with Cory & Dr. K: Part 1
127 ditonton
4:59
Understanding Duffy-null Phenotype in Children | Insights with Dr. Abraham Haimed
55 ditonton
17:03
Programa de Saneamiento en Embarcaciones: Proteccion de la salud publica en los cruceros desde 1975
194 ditonton